Todd Alfred Carter

CIK: 0001944011

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VYGR

Voyager Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

VYGR
Voyager Therapeutics, Inc.
Feb 24, 2026
Sale(S)
Direct
4.2K shares at avg. $3.76$16K
VYGR
Voyager Therapeutics, Inc.
Feb 18, 2026
Sale(S)
Direct
3.3K shares at avg. $3.44$11K
VYGR
Voyager Therapeutics, Inc.
Feb 10, 2026
Sale(S)
Direct
3.5K shares at avg. $3.85$14K
VYGR
Voyager Therapeutics, Inc.
Feb 6, 2026
Award(A)
Direct
33K shares-
VYGR
Voyager Therapeutics, Inc.
Feb 21, 2025
Award(A)
Direct
46K shares-
VYGR
Voyager Therapeutics, Inc.
Feb 20, 2025
Sale(S)
Direct
3.3K shares at avg. $4.26$14K
VYGR
Voyager Therapeutics, Inc.
Feb 11, 2025
Sale(S)
Direct
5.4K shares at avg. $4.45$24K
VYGR
Voyager Therapeutics, Inc.
Jan 14, 2025
Sale(S)
Direct
1.2K shares at avg. $5.13$6K

		Type	Shares	Price		Ownership
Feb 24, 2026	VYGR Voyager Therapeutics, Inc.	Sale(S)	4,174	$3.76	$15,694	Direct
Feb 18, 2026	VYGR Voyager Therapeutics, Inc.	Sale(S)	3,301	$3.44	$11,355	Direct
Feb 10, 2026	VYGR Voyager Therapeutics, Inc.	Sale(S)	3,525	$3.85	$13,571	Direct
Feb 6, 2026	VYGR Voyager Therapeutics, Inc.	Award(A)	33,000	-	$0	Direct
Feb 21, 2025	VYGR Voyager Therapeutics, Inc.	Award(A)	46,000	-	-	Direct
Feb 20, 2025	VYGR Voyager Therapeutics, Inc.	Sale(S)	3,305	$4.26	$14,079	Direct
Feb 11, 2025	VYGR Voyager Therapeutics, Inc.	Sale(S)	5,413	$4.45	$24,088	Direct
Jan 14, 2025	VYGR Voyager Therapeutics, Inc.	Sale(S)	1,191	$5.13	$6,110	Direct

1-8 of 8 transactions

About Carter Todd Alfred

Carter Todd Alfred (SEC CIK 0001944011) files insider reports with the SEC as Chief Scientific Officer of Voyager Therapeutics, Inc. (VYGR).

Signal8 holds 7 ownership filings by Carter Todd Alfred, all Form 4s, filed between Jan 15, 2025 and Feb 26, 2026. Those filings report 8 transactions, from Jan 14, 2025 to Feb 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Carter Todd Alfred's filings is in LEXINGTON, MA.

Recent filings by Carter Todd Alfred

Feb 24, 2026: Open-market sale of VYGR shares (Form 4, code S).
Feb 18, 2026: Open-market sale of VYGR shares (Form 4, code S).
Feb 10, 2026: Open-market sale of VYGR shares (Form 4, code S).
Feb 6, 2026: Grant or award of VYGR shares (Form 4, code A).
Feb 21, 2025: Grant or award of VYGR shares (Form 4, code A).

Other insiders filing for Voyager Therapeutics, Inc. (VYGR)

SCANGOS GEORGE A, Director
MACKEY CATHERINE J, Director
Hyman Steven, Director
Vitale Nancy, Director
Higgins Michael J, Director
Onyia Jude, Director

How to read Form 4 transaction codes